2052 Recruiting Trials

Clinical Trials
in Tennessee

Browse 2052 recruiting clinical trials currently enrolling participants in Tennessee. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 2052 recruiting trials in Tennessee

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
PHASE1 Duarte, California +4 sites · Metastatic Breast Cancer
Recruiting
Pan Tumor Rollover Study
PHASE2 Huntsville, Alabama +4 sites · Cancer
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
PHASE3 Birmingham, Alabama +4 sites · Low Grade Glioma, Low Grade Astrocytoma
Recruiting
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
PHASE1 Duarte, California +4 sites · Melanoma, Head and Neck Cancer
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA Birmingham, Alabama +4 sites · Ovarian Carcinoma
Recruiting
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
N/A Long Beach, California +4 sites · Pulmonary Embolism
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
N/A Anchorage, Alaska +4 sites · Malignant Solid Neoplasm
Recruiting
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
PHASE1 Birmingham, Alabama +4 sites · Metastatic Colorectal Cancer
Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
PHASE2 Anchorage, Alaska +4 sites · Advanced Extrapulmonary Neuroendocrine Carcinoma, Metastatic Extrapulmonary Neuroendocrine Carcinoma
Recruiting
A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
PHASE3 Phoenix, Arizona +4 sites · Stereotypical Prolonged Seizures
Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
PHASE1 Orange, California +4 sites · Locally Advanced Solid Tumor, Metastatic Solid Tumor
Recruiting
The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
N/A Memphis, Tennessee · Knowledge, Attitudes, Practice
Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy
Recruiting
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
PHASE2 Birmingham, Alabama +3 sites · Metastatic Breast Cancer, Invasive Mammary Carcinoma
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
PHASE3 Santa Barbara, California +4 sites · Non-Small Cell Lung Cancer (NSCLC)
Recruiting
See all 2052 results in Tennessee

Check Your Eligibility

Create a free profile and our AI will match you to trials in Tennessee you may qualify for.

Get Matched — Free
No insurance required
Search by Condition in Tennessee
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse Other States
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon